SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 58 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $77,000 | -29.4% | 14,200 | -2.7% | 0.00% | -33.3% |
Q1 2021 | $109,000 | -29.2% | 14,600 | +2.8% | 0.00% | -25.0% |
Q4 2020 | $154,000 | +20.3% | 14,200 | -2.1% | 0.00% | -33.3% |
Q3 2020 | $128,000 | -15.2% | 14,500 | +2.1% | 0.01% | -25.0% |
Q2 2020 | $151,000 | +1272.7% | 14,200 | +1094.3% | 0.01% | +700.0% |
Q2 2019 | $11,000 | +37.5% | 1,189 | +58.5% | 0.00% | 0.0% |
Q2 2018 | $8,000 | +60.0% | 750 | +53.1% | 0.00% | – |
Q4 2017 | $5,000 | -54.5% | 490 | -34.7% | 0.00% | -100.0% |
Q3 2017 | $11,000 | -42.1% | 750 | -37.8% | 0.00% | -50.0% |
Q2 2017 | $19,000 | – | 1,205 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
IFP Advisors, Inc | 50 | $1,000 | 0.00% |
Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |